The conference "Results and prospects of development of new polyphenolic drugs for cancer patients" took place at the N.N. Petrov National Medical Research Center of Oncology (PNMRCO) on May 31, 2017, and gathered researchers involved in development and evaluation of medicinal products based on the novel lignin-derived soluble polyphenolic polymer BP-Cx-1. BP-Cx-1 is the platform for a portfolio of innovative pharmacological products such as BP-C1, BP-C2 and BP-C3.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5725075 | PMC |
| http://dx.doi.org/10.18632/oncotarget.22307 | DOI Listing |
Publication Analysis
Top Keywords
prospects development
8
development polyphenolic
8
polyphenolic drugs
8
drugs cancer
8
cancer patients
4
patients conference
4
conference "results
4
"results prospects
4
cancer patients"
4
patients" place
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!